Anulex Technologies, Inc. Raises $10.2 Million in Series D Financing and Appoints New Senior Management.MINNEAPOLIS -- Anulex Technologies, Inc., a privately held medical device manufacturer focusing on spinal spinal /spi·nal/ (spi´n'l) 1. pertaining to a spine or to the vertebral column. 2. pertaining to the spinal cord's functioning independently from the brain. spi·nal adj. disc Preservation & Anular Repair(TM) products, announced the close of its fourth round of private equity financing Equity Financing The act of raising money for company activities by selling common or preferred stock to individual or institutional investors. In return for the money paid, shareholders receive ownership interests in the corporation. , totaling approximately $10.2 million. Investors leading the round include Affinity Capital, Delphi Ventures, MB Venture Partners, New Enterprise Associates, SightLine sight·line also sight line n. A line of sight, especially one between a spectator and the spectacle in a theater or stadium. Partners and Split Rock Partners. Commenting on the financing, Rich Lunsford, Anulex's President and Chief Executive Officer, said, "This financing will give us the ability to complete the enrollment and follow-up follow-up, n the process of monitoring the progress of a patient after a period of active treatment. follow-up subsequent. follow-up plan phases of our ground-breaking Xclose post market clinical study with the goal of providing further evidence to support the benefits of preservation and repair of the anulus. It will also provide additional investment for our U.S. commercialization efforts and further support the company's innovative research and development strategy." In addition, two new Vice Presidents have recently been appointed to Anulex's Senior Management Team. David M. Noel was appointed Vice President of Finance and Chief Financial Officer in February 2009. Prior to joining Anulex, Mr. Noel served in a similar role at Lifecore Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. , Inc. a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. which designed and marketed dental implants dental implant n. An artificial tooth that is anchored in the gums or jawbone to replace a missing tooth. dental implant and manufactures hyaluronan for use in various surgical markets. Matt Meyer was appointed Vice President of Sales and Marketing, in March 2009. Previously, Mr. Meyer served as Vice President of Marketing for KFx Medical, a privately held sports medicine sports medicine, branch of medicine concerned with physical fitness and with the treatment and prevention of injuries and other disorders related to sports. Knee, leg, back, and shoulder injuries; stiffness and pain in joints; tendinitis; "tennis elbow"; and device company. Prior to this position, Mr. Meyer served for over ten years, in a variety of senior marketing and sales positions, with Medtronic Spinal and Biologics. "We are delighted by the additions of David and Matt to the Anulex team. Both bring excellent experience in the medical device field as we continue to expand our market leadership position in anular repair", said Mr. Lunsford. About Anulex Anulex Technologies, Inc. is a privately held company dedicated to the development and commercialization of unique and proprietary soft tissue repair products with primary interests in treatments for the soft tissues of the spine. Back pain afflicts four out of every five individuals at some point during their life, and it is a major cause of disability. To date, Anulex has raised approximately $48.4 million through four rounds of financing to support these efforts. More information on the Company can be found at www.anulex.com. Xclose, Anulex, and Preservation & Anular Repair are trademarks of Anulex Technologies, Inc. |
|
|||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion